| 翻訳と辞書 |
Onepharm
Onepharm is a small, venture-financed Austrian biopharmaceutical company onepharm researches and develops products for periodontology. Originally focused on the development of antiviral drugs, it spun these activities out to a subsidiary, Savira Pharmaceuticals, in 2009.
==Creation==
The creation of onepharm was triggered by the desire of its parent company, AVIR Green Hills Biotechnology to divest itself of its drug development business and to focus entirely on vaccine development.〔(Eurofound article on the creation of onepharm ) Oct. 29, 2009 (Archived )〕 The new company, which had been a finalist for the Best of Biotech award, was founded in July 2005 and became operational in September 2005, with initial funding from two Austria Wirtschaftsservice credit programs. Two of the founders took the top management positions: Bernhard Küenburg, a former Senior Vice President of Marketing, Sales and Development at Siegfried (a Swiss custom manufacturer of active pharmaceutical ingredients) became the central executive officer; and Otto Dobblhoff-Dier, a professor of bioprocess engineering who had been Vice President for global manufacturing at the Vienna cancer vaccine company Igeneon AG prior to its acquisition by Aphton Corp., became chief operating officer.
Early in 2006 onepharm secured an EUR 2.7 million grant in funding from the Vienna Business Agency’s Center for Innovation and Technology, as part of a collaboration with the University of Natural Resources and Applied Life Sciences Vienna and the Vienna University of Technology.
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Onepharm」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|